Status:
RECRUITING
Compliance and Tolerance to Oral AntiBiotherapy in Osteoarticular Infections (OTABIO)
Lead Sponsor:
Hospices Civils de Lyon
Conditions:
Drug-Related Side Effects and Adverse Reactions
Treatment Adherence and Compliance
Eligibility:
All Genders
18+ years
Brief Summary
Bone and joint infections (BJI) are most often bacterial infections that can occur after surgery or de novo. They are rarely fatal in the short term, but are associated with significant morbidity, imp...
Eligibility Criteria
Inclusion
- ≥ 18 years
- Diagnosis of osteoarticular infection
- Treatment with at least one oral antibiotic for a minimum expected duration ≥ 6 weeks with an expected end of treatment date
- Patient who was informed and did not object to participate in the study
Exclusion
- Treatment for BJI with oral antibiotic without end of treatment date
- treatment for BJI with parenteral antibiotic only
- patient who doesn't have a telephone number or who doesn't want to give it
- Adults subject to a legal protection measure
- Pregnant or breastfeeding women
Key Trial Info
Start Date :
June 13 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 1 2026
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT05202964
Start Date
June 13 2024
End Date
September 1 2026
Last Update
February 13 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospices Civils de Lyon
Lyon, France, 69004